Global genetic devices maker
) has launched a new product, Axiom Strawberry Genotyping Array,
also known as International Strawberry 90K SNP array or IStraw90.
It is the world's first solution that facilitates high-resolution
genotyping and fully automated data analysis of the octoploid
strawberry genome. The array has been specifically designed to
facilitate Quantitative Trait Loci (QTL) discovery and
marker-assisted breeding of the cultivated garden strawberry.
AFFYMETRIX INC (AFFX): Free Stock Analysis
ACTELION LTD (ALIOF): Get Free Report
GENTIUM SPA-ADR (GENT): Free Stock Analysis
ISIS PHARMACEUT (ISIS): Free Stock Analysis
To read this article on Zacks.com click here.
The array has been developed in conjunction with the
International RosBREED SNP Consortium (IRSC), an arm of the
"RosBREED" project that conducts research on the genetic
improvement of rosaceous crops. Contrary to other genotyping
technologies that have been designed for diploids, AFFX's Axiom
Genotyping Solution is capable of accurately analyzing genotypes
of both diploid and polyploids species.
The new Axiom Strawberry Genotyping Array is yet another addition
to Affymetrix' Axiom Agrigenomics Genotyping Arrays that are
available for testing multiple species, including bovine,
chicken, and buffalo. Application of this new technology has
already achieved success with regard to complex genomes such as
maize, rose, wheat, trout, and salmon.
Scientists are confident that this innovative, technologically
advanced device will find application in various genome-wide
analysis and marker-assisted breeding in many American, European
and other breeding programs. Initial results from the array were
unveiled at the 2013 annual conference of the American Society
for Horticultural Science.
Earlier, Affymetrix rolled out the OncoScan FFPE Assay Kit, a
genome wide copy number assay for analyzing highly degraded
Formalin-fixed, paraffin-embedded (FFPE) solid tumor cancers. It
uses AFFX's state-of-the-art Molecular Inversion Probe (MIP)
technology to deliver prompt and accurate results in just 48
hours. The technologically advanced OncoScan FFPS Assay Kit is
considered superior to alternative methods such as FISH, array
CGH, and next-generation sequencing technologies.
Currently, Affymetrix has a Zacks Rank #4 (Sell). While we choose
to avoid this stock, companies like
Isis Pharmaceuticals, Inc.
) are expected to do well in the Medical-Biomed/Gene industry.
All these stocks carry a Zacks Rank #1 (Strong Buy).